AI-generated summary
The authors report a randomized, split-scalp study in 7 people with androgenetic alopecia, comparing 5% aminolevulinic acid photodynamic therapy on one half of the scalp with red-light therapy on the other. They found no significant improvement in hair density or hair growth with the photodynamic therapy compared with baseline, with mild edema and tolerable pain as the main adverse effects.
- Participants
- 7
- Who or what was studied
- Adults with androgenetic alopecia
- Limits stated in the abstract
- The study enrolled only 7 subjects, so the findings have limited statistical power and generalizability.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Androgenetic alopecia, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.